BU-NOT-SET

CONTACT US
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Global expansion in the CDMO field
  • Industry trends
Eyes
Insight
Fixed dose combinations - for improved patient compliance
  • Drug product
mini-tablets
Fact sheet
The current state of contract manufacturing
  • Industry trends
Eyes
Insight
eBook
  • Drug product
Golden rules for drug development
Fact sheet
  • Drug product
  • Manufacturing
Packaging services
Insight
  • Manufacturing
How has the pharmaceutical industry been affected by the pandemic?
Insight
  • Drug product
Achieving pharmaceutical serialisation on a global scale
Insight
  • Manufacturing
2021 packaging trends
Insight
  • Drug substance
Challenges of controlled release formulations
Fact sheet
  • Drug product
Stability studies and analysis for consumer health products
Insight
  • Analytical chemistry
Stability studies are ever changing: Outsourcing as a viable option
Insight
  • Drug substance
Navigating the regulatory landscape for controlled substances